Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurveys can estimate cumulative incidence for monitoring epidemics, requiring assessment of serologic assays to inform testing algorithm development and interpretation of results. We conducted a multilaboratory evaluation of 21 commerc...

Descripción completa

Detalles Bibliográficos
Autores principales: Stone, Mars, Grebe, Eduard, Sulaeman, Hasan, Di Germanio, Clara, Dave, Honey, Kelly, Kathleen, Biggerstaff, Brad J., Crews, Bridgit O., Tran, Nam, Jerome, Keith R., Denny, Thomas N., Hogema, Boris, Destree, Mark, Jones, Jefferson M., Thornburg, Natalie, Simmons, Graham, Krajden, Mel, Kleinman, Steve, Dumont, Larry J., Busch, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888213/
https://www.ncbi.nlm.nih.gov/pubmed/35202525
http://dx.doi.org/10.3201/eid2803.211885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888213/
https://www.ncbi.nlm.nih.gov/pubmed/35202525
http://dx.doi.org/10.3201/eid2803.211885

Ejemplares similares